Journal of Clinical Oncology, Vol 16, 1729-1735, Copyright © 1998 by American Society of Clinical Oncology

ARTICLES

Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute

MO Granovsky, BU Mueller, HS Nicholson, PS Rosenberg and CS Rabkin
Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. granovsm@epndce.nci.nih.gov

PURPOSE: To describe the spectrum of malignancies in human immunodeficiency virus (HIV)-infected children and the clinical outcome of patients with these tumors. METHODS: We retrospectively surveyed the Children's Cancer Group (CCG) and the National Cancer Institute (NCI) for cases of cancer that occurred between July 1982 and February 1997 in children who were HIV seropositive before or at the time of cancer diagnosis. We used Kaplan-Meier survivorship curves, hazard function estimates, and Cox proportional hazards models to evaluate survival. RESULTS: Sixty-four children (39 boys, 25 girls) with 65 tumors were reported. Thirty-seven children (58%) acquired HIV infection vertically (median age at cancer diagnosis, 4.3 years); 22 children (34%) acquired HIV through transfusion of blood or blood products (median age at cancer diagnosis, 13.4 years). Forty-two children (65%) had non- Hodgkin's lymphoma (NHL). Eleven children (17%) had leiomyosarcomas (or leiomyomas), which are otherwise exceptionally rare in children. Other malignancies included acute leukemia (five children), Kaposi's sarcoma (KS; three children), Hodgkin's disease (two children), vaginal carcinoma in situ (one child), and tracheal neuroendocrine carcinoma (one child). Median survival after NHL diagnosis was 6 months (range, 1 day to 89 months) and after leiomyosarcoma was 12 months (range, 10 days to 19 months). The average monthly death rate after NHL diagnosis was 12% in the first 6 months, which decreased to about 2% thereafter. In contrast, the monthly death rate after leiomyosarcoma diagnosis increased from 5% in the first 6 months to about 20% thereafter. CONCLUSION: After NHL, leiomyosarcoma is the second leading cancer in children with HIV infection. Both cancers have high mortality rates; improved outcome for NHL, in particular, may depend on earlier diagnosis and therapy.

This article has been cited by other articles:

				E. Chiappini, L. Galli, P.-A. Tovo, C. Gabiano, C. Lisi, C. Giaquinto, O. Rampon, G. C. Gattinara, G. De Marco, P. Osimani, et al. Cancer Rates After Year 2000 Significantly Decrease in Children With Perinatal HIV Infection: A Study by the Italian Register for HIV Infection in Children J. Clin. Oncol., January 1, 2007; 25(1): 97 - 101. [Abstract] [Full Text] [PDF]

				W. Tulvatana, C. Pancharoen, J. Mekmullica, U. Thisyakorn, U. Tinnungwattana, K. Keetacheeva, S. Shuangshoti, and S. Shuangshoti Epstein-Barr Virus-Associated Leiomyosarcoma of the Iris in a Child Infected With Human Immunodeficiency Virus Arch Ophthalmol, October 1, 2003; 121(10): 1478 - 1481. [Full Text] [PDF]

				B. H. Pollock, H. B. Jenson, C. T. Leach, K. L. McClain, R. E. Hutchison, L. Garzarella, V. V. Joshi, R. T. Parmley, and S. B. Murphy Risk Factors for Pediatric Human Immunodeficiency Virus-Related Malignancy JAMA, May 14, 2003; 289(18): 2393 - 2399. [Abstract] [Full Text] [PDF]

				S. Sei, D. P. O'Neill, S. K. Stewart, Q.-e. Yang, M. Kumagai, A. M. Boler, M. A. Adde, S. L. Zwerski, L. V. Wood, D. J. Venzon, et al. Increased Level of Stromal Cell-Derived Factor-1 mRNA in Peripheral Blood Mononuclear Cells from Children with AIDS-related Lymphoma Cancer Res., July 1, 2001; 61(13): 5028 - 5037. [Abstract] [Full Text] [PDF]

				M. Frisch, R. J. Biggar, E. A. Engels, J. J. Goedert, and for the AIDS-Cancer Match Registry Study Group Association of Cancer With AIDS-Related Immunosuppression in Adults JAMA, April 4, 2001; 285(13): 1736 - 1745. [Abstract] [Full Text] [PDF]

				A. M. Levine, D. T. Scadden, J. A. Zaia, and A. Krishnan Hematologic Aspects of HIV/AIDS Hematology, January 1, 2001; 2001(1): 463 - 478. [Abstract] [Full Text] [PDF]

				D. Caselli, C. Klersy, M. de Martino, C. Gabiano, L. Galli, P. A. Tovo, and M. Arico Human Immunodeficiency Virus-Related Cancer in Children: Incidence and Treatment Outcome--Report of the Italian Register J. Clin. Oncol., November 15, 2000; 18(22): 3854 - 3861. [Abstract] [Full Text] [PDF]

				R. J. Biggar, M. Frisch, J. J. Goedert, and for the AIDS-Cancer Match Registry Study Group Risk of Cancer in Children With AIDS JAMA, July 12, 2000; 284(2): 205 - 209. [Abstract] [Full Text] [PDF]

				B. U. Mueller Cancers in Children Infected With the Human Immunodeficiency Virus Oncologist, August 1, 1999; 4(4): 309 - 317. [Abstract] [Full Text]

				C. S. Rabkin, Q.-e. Yang, J. J. Goedert, G. Nguyen, H. Mitsuya, and S. Sei Chemokine and Chemokine Receptor Gene Variants and Risk of Non-Hodgkin's Lymphoma in Human Immunodeficiency Virus-1-Infected Individuals Blood, March 15, 1999; 93(6): 1838 - 1842. [Abstract] [Full Text] [PDF]